Clinical trial
Tetrabenazine for Partial Responders
NCT00362804 · Centre for Addiction and Mental Health, Other · Completed
Key facts
| NCT number | NCT00362804 |
|---|---|
| Title | Tetrabenazine for Partial Responders |
| Official title | Augmentation of Antipsychotic Partial Responders With Tetrabenazine |
| Lead sponsor | Centre for Addiction and Mental Health, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | Tetrabenazine |
| Enrollment | 41 |
| Start date | Feb 1, 2002 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Aug 10, 2006 |
| Last update posted | Jul 6, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: